CRWM
Castle Rock Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Buy |
3,545
+347
| +11% | +$143K | 0.34% | 85 |
|
|
2025
Q1 | $1.56M | Sell |
3,198
-131
| -4% | -$63.9K | 0.42% | 62 |
|
|
2024
Q4 | $1.77M | Buy |
3,329
+167
| +5% | +$88.8K | 0.42% | 64 |
|
|
2024
Q3 | $1.89M | Buy |
3,162
+57
| +2% | +$34K | 0.45% | 60 |
|
|
2024
Q2 | $1.68M | Buy |
3,105
+115
| +4% | +$62.3K | 0.42% | 65 |
|
|
2024
Q1 | $1.72M | Buy |
2,990
+1,189
| +66% | +$684K | 0.47% | 56 |
|
|
2023
Q4 | $956K | Buy |
1,801
+161
| +10% | +$85.5K | 0.29% | 95 |
|
|
2023
Q3 | $819K | Buy |
1,640
+43
| +3% | +$21.5K | 0.28% | 91 |
|
|
2023
Q2 | $831K | Buy |
1,597
+66
| +4% | +$34.4K | 0.28% | 85 |
|
|
2023
Q1 | $819K | Buy |
1,531
+22
| +1% | +$11.8K | 0.29% | 73 |
|
|
2022
Q4 | $871K | Buy |
1,509
+30
| +2% | +$17.3K | 0.39% | 65 |
|
|
2022
Q3 | $741K | Sell |
1,479
-18
| -1% | -$9.02K | 0.37% | 69 |
|
|
2022
Q2 | $829K | Sell |
1,497
-284
| -16% | -$157K | 0.42% | 57 |
|
|
2022
Q1 | $1.02M | Sell |
1,781
-1,651
| -48% | -$948K | 0.47% | 50 |
|
|
2021
Q4 | $1.99M | Sell |
3,432
-22
| -0.6% | -$12.8K | 0.81% | 32 |
|
|
2021
Q3 | $2.16M | Buy |
3,454
+191
| +6% | +$119K | 0.74% | 33 |
|
|
2021
Q2 | $1.76M | Buy |
3,263
+364
| +13% | +$197K | 0.65% | 39 |
|
|
2021
Q1 | $1.4M | Buy |
2,899
+244
| +9% | +$118K | 0.57% | 57 |
|
|
2020
Q4 | $1.37M | Buy |
2,655
+298
| +13% | +$153K | 0.57% | 50 |
|
|
2020
Q3 | $1.11M | Buy |
2,357
+1,067
| +83% | +$500K | 0.72% | 44 |
|
|
2020
Q2 | $536K | Buy |
+1,290
| New | +$536K | 0.31% | 110 |
|
|
2020
Q1 | – | Sell |
-4,130
| Closed | -$1.4M | – | 183 |
|
|
2019
Q4 | $1.4M | Buy |
+4,130
| New | +$1.4M | 1.26% | 13 |
|
|
2019
Q3 | – | Sell |
-800
| Closed | -$236K | – | 187 |
|
|
2019
Q2 | $236K | Buy |
+800
| New | +$236K | 0.26% | 118 |
|